Next Article in Journal
Development of Clinical-Grade Durvalumab-680LT and Nivolumab-800CW for Multispectral Fluorescent Imaging of the PD-1/PD-L1 Axis of the Immune Checkpoint Pathway
Previous Article in Journal
Interactions of Linalool and Linalyl Acetate with Selected Dog Cytochrome P450 (CYP) Proteins Identified by In Silico Drug Discovery Followed by Molecular Docking Analysis
 
 
Article

Article Versions Notes

Pharmaceuticals 2025, 18(10), 1500; https://doi.org/10.3390/ph18101500
Action Date Notes Link
article html file updated 9 October 2025 10:14 CEST Update https://www.mdpi.com/1424-8247/18/10/1500/html
article pdf uploaded. 9 October 2025 10:12 CEST Updated version of record https://www.mdpi.com/1424-8247/18/10/1500/pdf
article xml uploaded. 9 October 2025 10:12 CEST Update https://www.mdpi.com/1424-8247/18/10/1500/xml
article xml file uploaded 9 October 2025 10:12 CEST Update -
article html file updated 6 October 2025 09:50 CEST Original file -
article pdf uploaded. 6 October 2025 09:48 CEST Version of Record https://www.mdpi.com/1424-8247/18/10/1500/pdf-vor
article xml uploaded. 6 October 2025 09:48 CEST Update -
article xml file uploaded 6 October 2025 09:48 CEST Original file -
Back to TopTop